Shrimp anti-lipopolysaccharide factor peptide enhances the antitumor activity of cisplatin in vitro and inhibits HeLa cells growth in nude mice

Peptides

Volumn 31, Issue 6, 2010, Pages 1019-1025

  Lin, Ming Ching ^a   Lin, Shih Bin ^b   Chen, Jian Chyi ^c   Hui, Cho Fat ^a   Chen, Jyh Yih ^a  

^a INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^b NATIONAL ILAN UNIVERSITY   (Taiwan)

^c SOUTHERN TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Anti lipopolysaccharide factor; Cisplatin; Inhibition; Tumor growth

Indexed keywords

CASPASE 6; CASPASE 7; CASPASE 9; CISPLATIN; DEATH RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN BCL 2; SHRIMP ANTILIPOPOLYSACCHARIDE FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; MALE; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL MEMBRANE; CELL PROLIFERATION; CISPLATIN; HELA CELLS; HUMANS; MICE; MICE, NUDE; PEPTIDE FRAGMENTS;

DECAPODA (CRUSTACEA); MUS; MUS MUSCULUS;

EID: 77952107005     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.02.023     Document Type: Article

References (22)

1. Burz C., Berindan-Neagoe I., Balacescu O., and Irimie A. Apoptosis in cancer: key molecular signaling pathways and therapy targets. Acta Oncol 48 (2009) 811-821
2. Chen J., Xu X.M., Underhill C.B., Yang S., Wang L., Chen Y., et al. Tachyplesin activates the classic complement pathway to kill tumor cells. Cancer Res 65 (2005) 4614-4622
3. Chen J.Y., Lin W.J., Wu J.L., Her G.M., and Hui C.F. Epinecidin-1 peptide induces apoptosis which enhances antitumor effects in human leukemia U937 cells. Peptides 30 (2009) 2365-2373
4. Chen Y., Xu X., Hong S., Chen J., Liu N., Underhill C.B., et al. RGD-Tachyplesin inhibits tumor growth. Cancer Res 61 (2001) 2434-2438
5. Cruciani R.A., Barker J.L., Zasloff M., Chen H.C., and Colamonici O. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci USA 88 (1991) 3792-3796
6. Hoskin D.W., and Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 1778 (2008) 357-375
7. Lee H.S., Park C.B., Kim J.M., Jang S.A., Park I.Y., Kim M.S., et al. Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide. Cancer Lett 271 (2008) 47-55
8. Lin S.S., Huang H.P., Yang J.S., Wu J.Y., Hsia T.C., Lin C.C., et al. DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation caspases cascade- and mitochondrial-dependent pathway. Cancer Lett 272 (2008) 77-90
9. Lin W.J., Chien Y.L., Pan C.Y., Lin T.L., Chen J.Y., Chiu S.J., et al. Epinecidin-1, an antimicrobial peptide from fish (Epinephelus coioides) which has an antitumor effect like lytic peptides in human fibrosarcoma cells. Peptides 30 (2009) 283-290
10. Mai J.C., Mi Z., Kim S.H., Ng B., and Robbins P.D. A proapoptotic peptide for the treatment of solid tumors. Cancer Res 61 (2001) 7709-7712
11. Mora P., López De La Paz M., and Pérez-Payá E. Bioactive peptides derived from the Limulus anti-lipopolysaccharide factor: structure-activity relationships and formation of mixed peptide/lipid complexes. J Pept Sci 14 (2008) 963-971
12. Pan C.Y., Chao T.T., Chen J.C., Chen J.Y., Liu W.C., Lin C.H., et al. Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice. Int Immunopharmacol 7 (2007) 687-700
13. Pan C.Y., Chen J.Y., Lin T.L., and Lin C.H. In vitro activities of three synthetic peptides derived from epinecidin-1 and an anti-lipopolysaccharide factor against Propionibacterium acnes, Candida albicans, and Trichomonas vaginalis. Peptides 30 (2009) 1058-1068
14. Papo N., and Shai Y. Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 62 (2005) 784-790
15. Risso A., Braidot E., Sordano M.C., Vianello A., Macrì F., Skerlavaj B., et al. BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol Cell Biol 22 (2002) 1926-1935
16. Siddik Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22 (2003) 7265-7279
17. Sok M., Sentjurc M., and Schara M. Membrane fluidity characteristics of human lung cancer. Cancer Lett 139 (1999) 215-220
18. Somboonwiwat K., Marcos M., Tassanakajon A., Klinbunga S., Aumelas A., Romestand B., et al. Recombinant expression and anti-microbial activity of anti-lipopolysaccharide factor (ALF) from the black tiger shrimp Penaeus monodon. Dev Comp Immunol 29 (2005) 841-851
19. Tharntada S., Ponprateep S., Somboonwiwat K., Liu H., Söderhäll I., Söderhäll K., et al. Role of anti-lipopolysaccharide factor from the black tiger shrimp, Penaeus monodon, in protection from white spot syndrome virus infection. J Gen Virol 90 (2009) 1491-1498
20. Zachowski A. Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J 294 (1993) 1-14
21. Zhang C.X., and Lippard S.J. New metal complexes as potential therapeutics. Curr Opin Chem Biol 7 (2003) 481-489
22. Zhang Y., Qian H., Lin C., Lang J., Xiang Y., Fu M., et al. Adenovirus carrying TIMP-3: a potential tool for cervical cancer treatment. Gynecol Oncol 108 (2008) 234-240